ZURA BIO LTD - *W EXP 03/20/202 (ZURAW)

CUSIP: G9TY5A119

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / *W EXP 03/20/202
Total 13F shares
1,579,927
Share change
+236,595
Total reported value
$423,198
Price per share
$0.17
Number of holders
12
Value change
+$64,400
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G9TY5A119?
CUSIP G9TY5A119 identifies ZURAW - ZURA BIO LTD - *W EXP 03/20/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ZURA BIO LTD - *W EXP 03/20/202 (ZURAW) as of Q4 2023

As of 31 Dec 2023, ZURA BIO LTD - *W EXP 03/20/202 (ZURAW) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,579,927 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Boussard & Gavaudan Investment Management LLP, METEORA CAPITAL, LLC, KIM, LLC, WHITEBOX ADVISORS LLC, Walleye Capital LLC, CLEAR STREET LLC, Walleye Trading LLC, AQR Arbitrage LLC, and Warberg Asset Management LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.